Comments on: Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate

Comments on: Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate http://cmlhope.com/2004/06/27/efficacy-of-dual-specific-bcr-abl-and-src-family-kinase-inhibitors-in-cells-sensitive-and-resistant-to-imatinib-mesylate/ A Worldwide Support Network For Chronic Myelogenous Leukemia Wed, 28 Mar 2007 00:41:04 +0000 http://wordpress.org/?v=2.9.2 hourly 1